Approval Probability 71%
TA Base Rate26%
Adjusted LOA41%
ML RiskLOW_RISK
| NCT ID | Title | Phase | Status | Enrollment | Velocity | Design | Start | Completion | Last Updated | Sites | Countries |
|---|---|---|---|---|---|---|---|---|---|---|---|
| NCT00858195 | A Relative Bioavailability Study of 75mg Indomethacin Extended-Release Capsules | PHASE1 | COMPLETED | 36 | — | — | Jun 1, 2006 | Jul 1, 2006 | Mar 29, 2017 | - | — |
| Arm | Type | Description |
|---|---|---|
| 1 | EXPERIMENTAL | Indomethacin 75mg ER Capsules |
| 2 | ACTIVE_COMPARATOR | Indocin 75mg SR Capsules |
| Name | Type | Description |
|---|---|---|
| Indomethacin 75mg Extended-Release Capsules, Sandoz | DRUG | - |
| Indocin 75mg SR Capsules | DRUG | - |
Inclusion Criteria: * No clinically significant abnormal findings on physical exam, medical history or clinical laboratory results on screening Exclusion Criteria: * Positive test results for HIV or hepatitis B or C * No allergies to indomethacin or related drugs